TABLE 2.
Agonist/model | Inflammatory response |
---|---|
LPS intra-tracheal instillation | 1. Neutrophilic alveolitis; enhanced Nf-κB activation associate with aggravated lung injury in p47phox−/− mice.82,118 2. Decreased IL-10 production through attenuation of Akt-GSK3-β pathways in p47phox−/− mice.82 |
Zymosan intra-tracheal | Neutrophilic inflammation and augmented inflammatory cytokine production in p47phox−/− mice.119 |
Aspergillus fumigatus | 1. Invasive Aspergillosis, neutrophilic inflammation and granulomas in gp91phox−/− mice.120
2. Defective autophagy resulting in augmented IL-1β production that worsens inflammation in p47phox−/− mice.121 |
Tobacco smoke exposure | Exacerbated inflammation and lung emphysema in oxidase null (gp91phox−/− and p47phox−/−) mice.122 |
Gram negative sepsis | Enhanced PMN alveolar transmigration and acute lung injury in oxidase null mice (gp91phox−/− and p47phox−/−).123 |
Systemic inflammatory response syndrome (SIRS) | Early mortality due to hyper-inflammation and advanced lung pathology in oxidase null mice (gp91phox−/−).84 |
Necrotic cells/DAMPs | Leukocytosis, neutrophilia and elevated tissue accrual of neutrophils that prolongs inflammation gp91phox−/− mice.79,80 |
Branched β-glucans | Skin granulomas.81,83 |
Collagen induced arthritis | Enhanced T cell autoreactivity, and development of severe arthritis.85,124 |
Influenza model | Increased inflammatory cell infiltration, Th1 driving cytokines in gp91phox−/− mice.125 |